Status:
COMPLETED
Meta-analysis - Eltrombopag
Lead Sponsor:
GlaxoSmithKline
Conditions:
Thrombocytopaenia
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the meta-analysis was to explore the efficacy of eltrombopag versus placebo (standard of care)
Detailed Description
Meta-analysis of three studies: Bussell 2007 \& Bussell 2009 \& RAISE (TRA102537).
Eligibility Criteria
Inclusion
- Adults with ITP
- Received a pre-specified treatment
- Prospective clinical studies with at least 10 patients
Exclusion
- Subjects with ITP due to other causes
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT01235988
Start Date
August 1 2009
End Date
October 1 2009
Last Update
June 7 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.